Neurotech International’s world-first vision to treat neurological disorders in children with cannabinoid drug
A listed Australian biopharmaceutical development company says it has the potential to provide the world’s first approved cannabinoid drug therapy for neurological disorders, like autism, in children. Neurotech International is running clinical trials …